Second-Line Treatment Options for Advanced RCC

Optimising treatment for advanced RCC: Journey through a patient caseПодробнее

UROwebinar: Management of Metastatic kidney cancerПодробнее

Drs. McKay, Braun Share Strategies for Patient Selection in First-, Second-Line Advanced RCCПодробнее

Post-second-line systemic treatment for advanced RCCПодробнее

Clinical Management of 1L Advanced RCC Patients on CABOMETYX + OPDIVOПодробнее

Live Webinar on Management of renal cell carcinoma in the new millenniumПодробнее

Live Webinar on Management of renal cell carcinoma in the new millenniumПодробнее

Kidney Cancer Conference Highlights from ASCO GU 2023Подробнее

Educating Patients About First Line Treatment Options for Advanced Renal Cell CarcinomaПодробнее

Second-Line Treatment Options for RCCПодробнее

RCC: Current Applications, Controversies, and Future Use of Immunotherapy and Targeted AgentsПодробнее

Role of Surgery in Advanced Kidney Cancer - EMPIRE Urology Lecture SeriesПодробнее

CheckMate 9ER update confirms benefits of nivolumab–cabozantinib in RCC | Cristina SuárezПодробнее

Dr. Lee on Second-Line Treatment Options in RCCПодробнее

Selecting and Sequencing Targeted and Immunotherapy Regimens for Patients With RCCПодробнее

Second-Line Options for Poor-Risk Advanced RCCПодробнее

Management of First Line Advanced RCC in Era of Immuno-OncologyПодробнее

Winship Grand Rounds: May 19, 2021 - Mehmet Akce, MDПодробнее

Advanced RCC Treatment SelectionПодробнее
